Related Experiment Video
Updated: May 15, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Prevalence of parvovirus B 19 infection in children with aplastic anemia
Vineeta Gupta1, Isha Saini, Gopal Nath
1Departments of Pediatrics and *Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Insights
Parvovirus B19 infection is common in children with acquired aplastic anemia. This study found a higher prevalence of parvovirus B19 DNA and IgM antibodies in these patients compared to healthy children.
Area of Science:
- Pediatric Hematology
- Infectious Diseases
- Virology
Background:
- Acquired aplastic anemia in children can have various causes.
- Parvovirus B19 is a known cause of red blood cell aplasia.
Purpose of the Study:
- To investigate the prevalence of parvovirus B19 infection in pediatric patients diagnosed with acquired aplastic anemia.
- To compare the prevalence of parvovirus B19 infection in patients versus healthy controls.
Main Methods:
- Polymerase Chain Reaction (PCR) was used to detect parvovirus B19 DNA.
- Enzyme-Linked Immunosorbent Assay (ELISA) was used to detect parvovirus B19 IgM antibodies.
- 66 pediatric patients with acquired aplastic anemia and 45 healthy children were included.
Main Results:
- Parvovirus B19 DNA was detected in 27% of patients versus 2% of controls (P = 0.001).
- Parvovirus B19 IgM antibodies were found in 25.8% of patients compared to 2.2% of controls (P<0.05).
- No significant differences in clinical or hematological profiles were observed between infected and non-infected patients.
Conclusions:
- Parvovirus B19 infection is significantly more prevalent in pediatric patients with acquired aplastic anemia.
- The findings suggest a potential etiological role for parvovirus B19 in acquired aplastic anemia in children.
- Further research is warranted to explore the specific mechanisms and clinical implications.
Abstract:
We studied the prevalence of parvovirus B19 infection in pediatric patients with acquired aplastic anemia. Detection of parvovirus B19 DNA by PCR and IgM antibodies by ELISA was carried out in 66 pediatric patients with acquired aplastic anemia. 45 healthy children acted as controls. Parvovirus B19 DNA was detected in significantly higher number of patients in comparison to controls (27% vs 2%, P = 0.001). Similarly, parvovirus B19 IgM antibodies were detected in 17 (25.8%) patients as against one control (2.2%) (P<0.05). Clinical and hematological profile of the patients with or without parvovirus infection was comparable.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cytomegalovirus Disease
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...

